CRISPR Therapeutics CRSP

James R. Kasinger reports insider trading

James R. Kasinger, insider filing for CRSP

Form
4
Filed
Importance
Routine
  1. James R. Kasinger sold 1,990 shares on Oct 6, 2026
  2. Sold at an average price of $60.04
  3. Purchased 1,990 shares on Oct 6, 2026
  4. Purchased at a price of $13.62

Written from the Form 4 on EDGAR. Check the filing before you rely on it.

Get an email when CRISPR Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.